PExA

PExA AB Interim Report January - September 2024 released (in Swedish).

"With five scientific posters presented at the ERS Congress and a long-term U.S. customer investing in an upgrade during the period, we continue to drive impactful innovation and strengthen our leadership in the non-invasive small airway liquid biopsy field."
– Tomas Gustafsson

Read the full report on our website or through the link below: 👇🏼https://pexa.se/wp-content/uploads/2024/11/241108-PExA-AB-Delårsrapport-jan-sept-2024.pdf